The biallelic inactivation of FH leads to hereditary leiomyomatosis and renal cell cancer (HLRCC), a hereditary cancer syndrome characterized by the presence of benign tumours of the skin and uterus, and a highly malignant form of renal cell cancer1. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.